amgen want to own mm

2 of the most powerful cutting edge technologies working together to defeat Multiple Myeloma; it's VERY exciting to say the least!

Clearly Amgen want to dominate the MM space. This is incredible validation from Amgen's board and it's scientists, who see Pab's compound as being part of a one-two hit to knock MM for six!

We don't know what results this trial will bring. But there is a very good chance it will be far more powerful than either of these 2 treatments individually. If so, we might even see a virtual cure in most if not all patients!

It may well see Amgen owning the MM space completely.

With Amgen's money, this trial should have no troubles being completed rapidly. Then will they buy PAB out? Perhaps at a comparable valuation to Onyx?

Very exciting for PAB shareholders and MM sufferers and their families!